| Financial Year |
March 31 2023 |
| Monetary Funds |
8,327,952,509.66 |
| Held-for-trading Financial Assets |
1,760,331,423.80 |
| Notes Receivable |
-- |
| Accounts Receivable |
13,959,290.86 |
| Advances to Suppliers |
45,235,859.33 |
| Other Receivables |
10,058,219,768.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
47,530,981,765.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,495,919,709.48 |
| Total Current Assets |
70,232,600,327.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,360,437,438.76 |
| Investment Properties |
2,191,621,006.08 |
| Fixed Assetes |
368,051,922.60 |
| Under-construction Projects |
394,318.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,187,113,211.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,972,379.82 |
| Deferred Income Tax Assets |
2,241,509,305.86 |
| Other Non-Current Assets |
11,643,428.75 |
| Sub-Total of Non-Current Assets |
55,025,998,317.61 |
| Total Assets |
125,258,598,644.78 |
| Short-Term Loans |
5,974,411,586.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
424,454,812.15 |
| Accounts Payable |
2,669,584,187.39 |
| Accounts Received In Advance |
8,824,520.54 |
| Employee Compensation Payable |
16,458,733.15 |
| Taxes Payable |
1,084,117,657.03 |
| Interest Payable |
-- |
| Dividend Payable |
1,787,227.10 |
| Other payables |
5,541,564,504.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,624,450,099.85 |
| Other Current Liabilities |
6,637,803,489.12 |
| Sub-Total of Current Liabilities |
59,995,323,038.87 |
| Long-term Loans |
13,570,532,414.97 |
| Bonds Payable |
6,609,687,434.01 |
| Long-Term Accounts Payable |
121,702,453.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
64,341,135.22 |
| Other Non-Current Liabilities |
1,554,000,000.00 |
| Sub-Total of Non-Current Liabilities |
22,068,960,655.70 |
| Total Liabilities |
82,064,283,694.57 |
| Paid-In Capital(Or Share Stock) |
8,599,343,536.00 |
| Capital Surplus |
9,652,042,524.55 |
| Surplus Reserve |
1,427,713,385.06 |
| LESS:Treasury Stock |
327,887,586.31 |
| Undistributed Profits |
23,647,376,004.83 |
| Minority Stockholder's Interest |
806,930,349.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
42,387,384,600.88 |
| Owner's Equity（Stockholder's Equity） |
43,194,314,950.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
125,258,598,644.78 |
